Sengenics
Dr. Arif Anwar, co-founder and former Sengenics CEO, has a prodigious track record spanning more than 20 years of success in commercializing cutting-edge life science technologies. He has held progressively senior positions in genomics, bioinformatics, and proteomics companies in the U.S., the UK and Singapore. His previous roles have included Co-Founder and Commercial Director of PhenoCure UK Ltd., Regional Director at DoubleTwist Inc. and Regional Manager at Clontech. He earned a PhD in biochemistry and a BSc in genetics from University College London.
This person is not in the org chart
This person is not in any offices
Sengenics
Sengenics is a functional proteomics company that leverages its patented KREX™ technology for production of full-length, correctly folded and functional proteins. KREX™ was invented and patented by Professor Jonathan Blackburn whilst he was a member of the faculty at the University of Cambridge.